The global Hemapheresis market is anticipated to grow at a CAGR of around 6.8% during the forecast period (2021-2027). The growth of the hemapheresis market is mainly driven due to the increasing mergers and acquisitions, and partnership collaborations among major players to further expand their business and product pipeline. For instance, in February 2021, Cerus Corp and Shandong Zhongbaokang Medical Implements Co. Ltd. (ZBK) came into a joint venture (JV) to develop and obtain regulatory approval to manufacture and commercialize the INTERCEPT Blood System for platelets and red blood cells in China. Moreover, in January 2021, Haemonetics Corp. completed the acquisition of privately-held Cardiva Medical, Inc. for $475 million at closing through a definitive agreement. The acquisition comprises the VASCADE vascular closure system of Haemonetics Corp., along with its all assets. Through this acquisition, the company aimed to expand and diversifies hospital offerings in the large and growing interventional cardiology and electrophysiology markets.
Browse the full report description of "Global Hemapheresis Market Size, Share & Trends Analysis Report By Technology (Centrifugation, Membrane Separation, and Selective Adsorption) By Product (Devices, and Disposable) By Procedure (Photopheresis, Plasmapheresis, and Others) By Application (Hematology, Neurology, and Others) Forecast, 2021-2027" at https://www.omrglobal.com/industry-reports/hemapheresis-market
In September 2019, Baxter International Inc. announced the acquisition of Cheetah Medical, a leading provider of non-invasive hemodynamic monitoring technologies. The acquisition was done for $190 million. By acquiring Cheetah Medical, the company aimed to improve clinical outcomes with an established patient monitoring technology. Similarly, in October 2019, Asahi Kasei Medical has completed the acquisition of Virusure Forschung und Entwicklung GmbH (ViruSure), an Austrian provider of biosafety testing services. Through this acquisition, Asahi Kasei Medical expanded its bioprocess business, for biotherapeutics such as plasma derivatives and biopharmaceuticals.
The increasing government support in form of grants for further R&D in hemapheresis devices is also boosting the market growth. For instance, in April 2021, Baxter International Inc. received R&D grant funding of €1.5 million from the German Federal Ministry of Education and Research. The grant will aid Baxter to create a new technology platform for further enhancing its ability to target selective removal of pathogenic substances during blood purification therapies.
Market Coverage
o By Technology
o By Product
o By Procedure
o By Application
o North America
o Europe
o Asia-Pacific
o Rest of the World
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Hemapheresis Market Report Segment
By Technology
By Product
By Procedure
By Application
Global Hemapheresis Market Report by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/hemapheresis-market